Wednesday November 25 2009 | Biotechnology feed | All feeds
|
|
CoTherix, Inc.
Download detailed PDF Members: CoTherix, Inc. (Nasdaq: CTRX) is a biopharmaceutical company focused on licensing, developing and commercializing therapeutic products for the potential treatment of cardiopulmonary and other chronic diseases. Our business strategy is focused on in-licensing product opportunities that are in mid- to late-stage clinical development. Our in-depth understanding of the biology of cardiopulmonary and other diseases—combined with our management’s development, commercialization and business experience—is highly advantageous as we continue to identify and acquire product candidates in our target disease markets
This page has been viewed 306 times since April 2007, the link to the organisation's website has been followed 53 times Recent Search Terms used to find this page: CoTherix Inc. | CoTherix Inc. | . Search for more companies in South San Francisco Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for CoTherix, Inc. | |||||||||||||||||||||||||||||||||||||||||
|